We provide rescue medicines typically used in emergency rooms and intensive care units to treat patients for whom there are limited treatment options. We are dedicated to delivering quality medicines that make a real difference to patients and their families through the development, manufacture, and commercialisation of pharmaceutical products. Our current portfolio of antidotes counteract certain snake venoms and the toxicity associated with some heart and cancer medications.
When Choosing Antivenin, Look at Cost Per Treatment—Not Cost Per Vial
Recent NASBR data suggests that the difference in total treatment cost between antivenom products is probably much less than healthcare providers think.
Why We Are Joining the UN Global Compact as Part of Our Broader Strategy
Learn how BTG Pharmaceuticals, a SERB company, is becoming better environmental stewards, more responsive to our people and respectful of our responsibilities as an organisation
Household Fires Can Cause Cyanide Poisoning – Here’s What Medical Professionals Can Do
Smoke inhalation from domestic fires is the most common cause of cyanide poisoning in developed countries, with significant levels of cyanide present in up to 35% of all fire victims.